| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in LUNG over the last quarter tilts toward selling: insiders offloaded a net 78,340 shares worth roughly $177K.
LUNG sits in the Health Care Equipment & Supplies industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 1.34M | - | - | |
| CEO | 1.14M | $2.57M | - | |
| Other | 449.8K | $1.02M | - | |
| Other | 361.8K | $817.7K | - | |
| Other | 317.0K | $716.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | French Glendon E. III84 | President and CEO | Sell | 41,882 | $2.26 | $94,653.32 | -3.5% | - | - | |
| Sep 1, 2026 | Lehman David Aaron79 | General Counsel | Sell | 14,334 | $2.26 | $32,394.84 | -3.8% | - | - | |
| Sep 1, 2026 | Radhakrishnan Srikanth | Chief Science &Techn. Officer | Sell | 14,245 | $2.26 | $32,193.70 | -4.3% | - | - | |
| Sep 1, 2026 | Rose Geoffrey Beran81 | Chief Commercial Officer | Sell | 7,879 | $2.26 | $17,806.54 | -1.7% | - | - | |
| Jun 2, 2026 | French Glendon E. III84 | President and CEO | Sell | 56,149 | $1.55 | $86,874.79 | -4.5% | +47.8% | - | |
| Jun 1, 2026 | Lehman David Aaron79 | General Counsel | Sell | 14,594 | $1.54 | $22,474.76 | -3.7% | +49.7% | - | |
| Jun 1, 2026 | Rose Geoffrey Beran81 | Chief Commercial Officer | Sell | 8,023 | $1.54 | $12,355.42 | -1.7% | +49.7% | - | |
| Jun 1, 2026 | Radhakrishnan Srikanth | Chief Science &Techn. Officer | Sell | 14,497 | $1.54 | $22,325.38 | -4.2% | +49.7% | - | |
| Mar 2, 2026 | French Glendon E. III84 | President and CEO | Sell | 67,813 | $1.43 | $96,972.59 | -4.6% | +4.3% | - | |
| Mar 2, 2026 | Lehman David Aaron79 | General Counsel | Sell | 12,237 | $1.43 | $17,498.91 | -4.8% | +4.3% | - |